|
|
| MRD / Regn No. |
: MH/23-24/02357 |
Date |
: 01/06/2026 |
| Patient Name |
: Vijayalakshmi |
Age & Gender |
: 49 Yrs. / Female |
| Contact No. |
: 9500743460 |
UHID |
: |
| Ht / Wt / BMI |
: / 56 / |
BP S / BP D |
: 110 / 70 |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM - UNCONTROLLED (22/Oct/2025) | CAD (22/Oct/2025) | |
|
Subjective |
: |
PAIN LEFT SHOULDER |
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 182 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 281 100 | HBA1C GLYCOSYLATED HEMOGLOBIN: 7.1 mg/dL | UREA: 20 mg/dL | CREATININE: 0.8 1 | EGFR EGLOMERULAR FILTRATION RATE: 81.65 mL/min/1.73m2 | TOTAL CHOLESTEROL: 185 1 | TGL TRIGLYCERIDE: 113 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 43 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 115 mg/dL | SODIUM: 136 meq/L | POTASSIUM: 4.3 1 | CHLORIDE: 104 meq/L | BICARBONATE: 23 meq/L | HB HEMOGLOBIN: 12.1 g/dL | WBC WHITE BLOOD CELLS: 4000 K/uL | LYMPHOCYTES: 19 | MONOCYTES: 12 | PLATELETS: 185000 X10^9/L | TOTAL T3: 2.61 1 | TOTAL T4: 1.20 1 | TSH THYROID STIMULATING HORMONE: 3.706 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET DAPAGLIFLOZIN 10 + SITAGLIPTIN 100
UDAPA - S |
|
1-0-0 |
AFTER FOOD
|
|
|
|
2 |
TABLET RABEPRAZOLE + DOMPERIDONE
RABIWIN D |
ORAL |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
3 |
TABLET VOGLIBOSE 0.2MG
VOGLIWIN 0.2
Medicine For DIABETES |
ORAL |
1-0-1 |
WITH FOOD
|
TILL NEXT VISIT |
|
|
4 |
TABLET GLIMEPRIDE 0.5MG + METFORMIN 500MGSR
GLYCOMET GP 0.5 |
|
0-0-1 |
|
|
|
|
5 |
TABLET GLIMEPRIDE 2 +METFORMIN 500
GLIMIWIN M2 |
ORAL |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 01/Jul/2026 |
| Tests Suggested For Next Visit |
: |
| |
|
| |
|
